NCT05486650View on ClinicalTrials.gov

An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

PD-1 inhibitor

After receiving PD-1 inhibitor treatment in the first three cycles, patients with locally advanced or advanced NSCLC whose curative effect is evaluated as stable disease receive SBRT combined with PD-1 inhibitor treatment

Trial Locations (1)

40037

RECRUITING

the second affiliated hospital of Army medical university, Chongqing

All Listed Sponsors
lead

Xinqiao Hospital of Chongqing

OTHER